View Press Releases

  • FDA Renews and Expands its Use of Certara Software to Facilitate New Drug and Biologics Regulatory Review

    PRINCETON, NJ, US - Oct 9, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, today announced that the US Food and Drug Administration (FDA) has renewed, and in many cases increased, its number of Certara software licenses for reviewing new drug and biologics applications

    Oct 9, 2018

  • BioIVT Acquires UK-based Clinical Trials Laboratory Services

    WESTBURY, NY, US - Oct 8, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced that it has acquired Clinical Trials Laboratory Services (CTLS), a donor center and laboratory based in London, UK

    Oct 8, 2018

  • Repositive launches limited-time free Personal Shopper Service, to connect researchers with difficult-to-source translational cancer models

    CAMBRIDGE, UNITED KINGDOM - Oct 8, 2018 - Repositive launches limited-time free Personal Shopper Service, to connect researchers with difficult-to-source translational cancer modelsRepositive, the Cambridge (UK) tech start-up that connects oncology researchers with the world of cancer models and the services they require to develop new treatments and cures, has announced a limited-time, free of charge, introductory service to its Cancer Models product

    Oct 8, 2018

  • Solentim Wins Two Queen’s Awards for Enterprise

    WIMBORNE, UK - Oct 8, 2018 - Solentim, a leading provider of instrumentation used by biopharma companies in the fields of mammalian cell line development and cell culture, has received two Queen's Awards for Enterprise, one for International Trade and one for Innovation

    Oct 8, 2018

  • Certara to Participate in 40 Pharmacometrics Modeling and Simulation Sessions at ACoP9

    PRINCETON, NJ, US - Oct 5, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, today announced that it is participating in 40 sessions at the ninth American Conference on Pharmacometrics (ACoP9)

    Oct 5, 2018

  • CluePoints Strengthens Senior Team with Two Key Appointments

    WAYNE, PA - Oct 4, 2018 - CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has announced the appointment of two industry thought-leaders to its senior team, as it continues its impressive global growth throughout North America, Europe and Asia Pacific

    Oct 4, 2018

  • Riffyn launches Open Access for scientists at non-profits

    OAKLAND, CA - Oct 3, 2018 - Oakland, CA, USA, 3rd October 2018 / Riffyn, a global provider of cloud-based experiment design and data analytics software, has launched Riffyn Open Access which provides free use of its patented Scientific Development Environment (SDE™) to any member of a non-profit organization

    Oct 3, 2018

  • Innovate UK Awards Medherant a Medicines Manufacturing Grant

    COVENTRY, UK - Oct 3, 2018 - Medherant, a developer of innovative transdermal drug delivery treatments for pain and CNS diseases, has been awarded a Medicines Manufacturing Grant by Innovate UK

    Oct 3, 2018

  • SynbiCITE launches new five-year strategy

    LONDON, UK - Oct 2, 2018 - SynbiCITE, the UK’s national centre for commercialisation of synthetic biology, is pleased to announce the launch of a new five-year strategy underpinned by a new £5M grant from UKRI and other sources

    Oct 2, 2018

  • CRF Health, a CRF Bracket Company, Brings Industry Together to Lead Debate with eCOA Forum

    PLYMOUTH MEETING, PA - Oct 2, 2018 - CRF Health, a CRF Bracket company, the leading provider of patient-centered eSource technology solutions for the life sciences industry, today unveiled details of its 2018 eCOA Forum

    Oct 2, 2018

  • Knockout (KO) Validation

    CAMBRIDGE, UNITED KINGDOM - Oct 2, 2018 - Antibodies are widely used in pre-clinical research to study proteins and their functions in biological pathways and diseased states

    Oct 2, 2018

  • Protein Dynamic Solutions recipient of NSF SBIR Phase IIB Supplemental award

    WAKEFIELD, MA - Oct 1, 2018 - Protein Dynamic Solutions (PDS) was awardeda Small Business Innovation Research (SBIR) Phase IIB grant from the National Science Foundation (NSF) to focus on innovative breakthrough applications and commercialization of ProteinMentorTMplatform technology for pre-clinical candidate selection and to help ensure safety and efficacy of therapeutic proteins

    Sep 30, 2018

  • UgenTec to extend its software portfolio with FastTyper, a platform used for high-throughput SNP genotyping by end-point PCR

    BOSTON, MA - Sep 28, 2018 - UgenTec today announced a new end-point PCR analysis software called FastTyper. FastTyper uses artificial intelligence (AI) methods to significantly accelerate genotyping analysis workflows and improve data interpretation in applications such as agricultural breeding programs

    Sep 28, 2018

  • Symbiosis secures FDA viral vector process approval

    NEWCASTLE UPON TYNE, UNITED KINGDOM - Sep 27, 2018 - Stirling, UK – SYMBIOSIS Pharmaceutical Services, a fast-growing specialist sterile manufacturing CDMO, has reported FDA approval for its viral vector manufacturing fill/finish process at its biologics manufacturing facility located in Scotland, UK

    Sep 27, 2018

  • Major international FDA-led study confirms CellOPTIQ® High Content Assay as leading in vitro platform to assess cardiotoxicity in new drugs

    MOTHERWELL, SCOTLAND - Sep 27, 2018 - Clyde Biosciences, the leader in cardiac cell function assessment, announced today that its proprietary CellOPTIQ® High Content Assay (HCA) outperformed other assay types in the global CiPA myocyte study designed to develop more accurate and comprehensive in vitro  cardiac safety evaluation of new drugs

    Sep 27, 2018

  • Thermo Fisher Scientific Expands Genome Editing IP Portfolio

    CARLSBAD, CA, UNITED STATES - Sep 18, 2018 - Thermo Fisher Scientific, Inc., the world leader in serving science, has licensed CRISPR technologies from the Broad Institute and ERS Genomics (foundational University of California IP) to bolster its genome editing intellectual property (IP) portfolio

    Sep 26, 2018

  • Qlucore AB announces changes to Board of Directors

    GUILDFORD, UNITED KINGDOM - Sep 26, 2018 - Pia Gideon has been appointed Chair, having served on the Board of Qlucore AB since 2009. She was previously the Vice President of Marketing and Communication at Ericsson

    Sep 26, 2018

  • Certara Launches BaseCase® Portal™, Enabling Life Sciences Companies to Deliver Therapeutic Decision-making Apps to HCPs at the Point of Care

    PRINCETON, NJ, US - Sep 26, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, announced today the launch of its BaseCase Portal cloud-based platform, that allows for the rapid creation of fully-customizable mobile apps that connect live to mathematical models and algorithms, and help HCPs optimize treatment for individual patients

    Sep 26, 2018

  • LabKey and Linguamatics Partner to Extract Clinical Insights from Big Data in Healthcare

    CAMBRIDGE, N/A, UNITED KINGDOM - Sep 25, 2018 -  Linguamatics, the leading natural language processing (NLP) text analytics provider, and LabKey, a provider of bioinformatics data management solutions, today announced an integrated solution designed to streamline the extraction and curation of valuable insights from large volumes of unstructured clinical notes and reports

    Sep 25, 2018

  • Quanticate partners with CluePoints™ to offer Data Quality Oversight

    LONDON, UNITED KINGDOM - Sep 25, 2018 - Quanticate, a data-focused clinical research organisation (CRO), has announced that it has partnered with CluePoints™ to utilize their software to drive the statistical analysis to perform data integrity checks on all types of monitoring and investigator site data as part of its new Data Quality Oversight service that enables centralized statistical monitoring, in response to the  amendments to the ICH Good Clinical Practice (GCP) E6(R2) guidelines

    Sep 25, 2018